{"date":"2025-04-15","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6666-2025-04-15-1806-1bkm0mx","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-04-15","time":"18:06:24","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-04-15 18:06，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-04-15-1749-13rpxz5","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-04-15","time":"17:49:48","subject":"公告本公司訂定除息基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-04-15 17:49，「公告本公司訂定除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-04-15-1735-1qvbl4l","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-04-15","time":"17:35:58","subject":"公告本公司董事會決議通過解除經理人競業禁止之限制案","clause":"第22款","fact_date":"2025-04-15","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-04-15 17:35，「公告本公司董事會決議通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-04-15-1735-9rq3jk","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-04-15","time":"17:35:40","subject":"公告本公司重要經理人晉升","clause":"第11款","fact_date":"2025-04-15","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-04-15 17:35，「公告本公司重要經理人晉升」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-04-15-1735-1v376rb","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-04-15","time":"17:35:21","subject":"本公司董事會決議召開113年股東常會補充公告(新增議案)","clause":"第32款","fact_date":"2025-04-15","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-04-15 17:35，「本公司董事會決議召開113年股東常會補充公告(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2025-04-15-1701-bcgk77","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2025-04-15","time":"17:01:48","subject":"本公司因違反性別平等工作法遭裁罰新台幣30萬元整並提請訴願。","clause":"第21款","fact_date":"2024-03-28","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2025-04-15 17:01，「本公司因違反性別平等工作法遭裁罰新台幣30萬元整並提請訴願。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-04-15-1632-13b5xld","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-04-15","time":"16:32:06","subject":"公告本公司董事會決議分派現金股利","clause":"第31款","fact_date":"2025-04-15","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-04-15 16:32，「公告本公司董事會決議分派現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-04-15-1601-3rc8x5","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-04-15","time":"16:01:47","subject":"本公司董事會通過113年度合併財務報告","clause":"第43款","fact_date":"2025-04-15","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-04-15 16:01，「本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2025-04-15-1547-dx5kuf","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2025-04-15","time":"15:47:41","subject":"公告本公司副總經理、代理發言人異動","clause":"第11款","fact_date":"2025-04-15","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2025-04-15 15:47，「公告本公司副總經理、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-04-15-1516-om8fyo","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-04-15","time":"15:16:31","subject":"代重要子公司意能生技股份有限公司公告董事會訂定現金增資認股基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-04-15 15:16，「代重要子公司意能生技股份有限公司公告董事會訂定現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-04-15-1507-j5ij9z","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-04-15","time":"15:07:30","subject":"代重要子公司意能生技股份有限公司公告114年第一次普通股暨特別股股東臨時會重要決議事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-04-15 15:07，「代重要子公司意能生技股份有限公司公告114年第一次普通股暨特別股股東臨時會重要決議事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}